# Dark Blue Therapeutics Ltd

## Details

- **Company number:** [12645831](https://find-and-update.company-information.service.gov.uk/company/12645831)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 4 Jun 2020
- **Registered office:** HAYAKAWA BUILDING, EDMUND HALLEY ROAD, THE OXFORD SCIENCE PARK, OXFORD, OX4 4GB
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [Amgen UK Holdings Limited](/group/21139) (3 companies)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WALKER, Christopher Paul | director | 30 Dec 2025 | 3 Jul 2026 |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Andrew James Mclean | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 4 Jun 2020 | 24 Jul 2020 |
| Oxford Science Enterprises Plc | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 24 Jul 2020 | 17 Oct 2022 |
| Evotec International Gmbh | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 21 Oct 2022 | 28 Jun 2024 |
| Oxford Science Enterprises Plc | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 28 Jun 2024 | 30 Dec 2025 |
| Bms Strategic Portfolio Investments Holdings, Inc. | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 17 Oct 2022 | 30 Dec 2025 |
| Amgen Uk Holdings Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 30 Dec 2025 |  |




## Owned by

Dark Blue Therapeutics Ltd → [Amgen UK Holdings Limited](/company/16897338)



## Controls

- [Kleidox Therapeutics Ltd](/company/12998606) (12998606)
- [Sandymount Therapeutics Ltd](/company/13514842) (13514842)